Galectin Therapeutics Inc. (GALT) DCF Valuation

Galectin Therapeutics Inc. (GALT) DCF Valuation

US | Healthcare | Biotechnology | NASDAQ
Galectin Therapeutics Inc. (GALT) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Galectin Therapeutics Inc. (GALT) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Gain insights into your Galectin Therapeutics Inc. (GALT) valuation analysis with our sophisticated DCF Calculator! This Excel template is preloaded with real GALT data, enabling you to adjust forecasts and assumptions for an accurate calculation of Galectin Therapeutics Inc.'s intrinsic value.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -13.2 -23.3 -30.0 -37.7 -.2 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .0 .0 .0 .0 38.1 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -13.2 -23.4 -30.0 -37.7 -38.3 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 47.5 27.1 39.6 18.6 25.7 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 1.7 1.3 1.8 3.9 6.4 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -13.3 -23.4 -30.5 -38.2 -38.3 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -11.6 -23.8 -29.9 -36.0 2.3 -6.4 .0 .0 .0 .0
WACC, % 5.91 5.91 5.91 5.91 5.91 5.91 5.91 5.91 5.91 5.91
PV UFCF
SUM PV UFCF -6.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -6
Net Debt 46
Equity Value -52
Diluted Shares Outstanding, MM 60
Equity Value Per Share -0.87

What You Will Get

  • Real GALT Financial Data: Pre-filled with Galectin Therapeutics’ historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Galectin Therapeutics’ intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • 🔍 Real-Life GALT Financials: Pre-filled historical and projected data for Galectin Therapeutics Inc. (GALT).
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) such as WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Galectin’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Galectin’s valuation instantly after making adjustments.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Galectin Therapeutics Inc. (GALT) data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Galectin Therapeutics Inc. (GALT)'s intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for Galectin Therapeutics Inc. (GALT)?

  • Accurate Data: Utilize real Galectin Therapeutics financials for dependable valuation outcomes.
  • Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
  • Time-Saving: Pre-constructed calculations save you from starting over.
  • Professional-Grade Tool: Tailored for investors, analysts, and consultants in the biotech sector.
  • User-Friendly: Easy-to-navigate design and clear instructions cater to users of all experience levels.

Who Should Use This Product?

  • Healthcare Investors: Develop comprehensive and accurate valuation models for analyzing Galectin Therapeutics Inc. (GALT).
  • Pharmaceutical Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the company.
  • Consultants and Advisors: Offer clients precise valuation insights regarding Galectin Therapeutics Inc. (GALT).
  • Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
  • Biotech Enthusiasts: Gain insights into how biotech companies like Galectin Therapeutics Inc. (GALT) are valued in the market.

What the Template Contains

  • Pre-Filled DCF Model: Galectin Therapeutics Inc.’s (GALT) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital specific to Galectin Therapeutics Inc. (GALT).
  • Financial Ratios: Evaluate Galectin Therapeutics Inc.’s (GALT) profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios for Galectin Therapeutics Inc. (GALT).
  • Financial Statements: Annual and quarterly reports for Galectin Therapeutics Inc. (GALT) to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results for Galectin Therapeutics Inc. (GALT).

No products were found matching.